Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging.
about
Sympathetic nervous system overactivity and its role in the development of cardiovascular diseaseAdrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.Can the measurement of brachial artery flow-mediated dilation be applied to the acute exercise model?Local tetrahydrobiopterin administration augments cutaneous vasoconstriction in aged humans.Localized tyrosine or tetrahydrobiopterin supplementation corrects the age-related decline in cutaneous vasoconstriction.An age-dependent interaction with leptin unmasks ghrelin's bone-protective effectsRegular physical exercise improves cardiac autonomic and muscle vasodilatory responses to isometric exercise in healthy elderlyPersonality traits modulate emotional and physiological responses to stress.Sex differences with aging in nutritive skeletal muscle blood flow: impact of exercise training, nitric oxide, and α-adrenergic-mediated mechanisms.Pupillary behavior in relation to wavelength and age.Exercise attenuates the major hallmarks of aging.Effects of betel nut on cardiovascular risk factors in a rat modelLack of age-related increase in carotid artery wall viscosity in cardiorespiratory fit men.Characterizing sympathetic neurovascular transduction in humans.Strength and vulnerability integration: a model of emotional well-being across adulthood.Tetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.The effect of aging on adrenergic and nonadrenergic receptor expression and responsiveness in canine skeletal muscleAging, metabolic syndrome and the heart.Effects of life-long caloric restriction and voluntary exercise on age-related changes in levels of catecholamine biosynthetic enzymes and angiotensin II receptors in the rat adrenal medulla and hypothalamus.Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy.Salivary Alpha-Amylase Reactivity in Breast Cancer Survivors.Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effectsAdvanced age decreases local calcium signaling in endothelium of mouse mesenteric arteries in vivo.Age Impaired endothelium-dependent vasodilation is improved by resveratrol in rat mesenteric arteries.Calorie restriction and cardiometabolic health.Blood pressure regulation: every adaptation is an integration?Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertensionRenal microvascular disease in an aging population: a reversible process?Diurnal profiles of salivary cortisol and alpha-amylase change across the adult lifespan: evidence from repeated daily life assessments.Neuro-hormonal effects of physical activity in the elderly.Exercise protects the cardiovascular system: effects beyond traditional risk factors.BP regulation VI: elevated sympathetic outflow with human aging: hypertensive or homeostatic?Neural Control of Vascular Function in Skeletal Muscle.Role of p53 in cAMP/PKA pathway mediated apoptosis.A brief review of intradialytic hypotension with a focus on survival.Developmental Programming of Hypertension: Physiological Mechanisms.Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.Salivary alpha-amylase stress reactivity across different age groups.Sympathetic and haemodynamic responses to lipids in healthy human ageing.
P2860
Q28279754-56C53E4E-5A8D-46B1-A1CA-0F83B4C32A82Q28593269-39297A25-5260-49F3-BD6E-89869268BCD5Q30385053-4E321CAA-D86D-4BB7-9D18-7EA0358AE4EFQ30481092-0A8DB2AA-44A3-468A-9C1B-9463737102EAQ33459010-30064887-B28F-4152-9511-799AEDFEBA2FQ33533536-A4D511AC-09BA-468D-B726-345E22FC712BQ33569660-5D45E834-3C12-445C-BB58-C8D8700988B0Q33881106-BCC0AD27-992A-47B3-BE74-5156834C94C3Q33992256-0E6189C3-8889-4BCA-A4F5-1D4C84B8401DQ34062832-621E0755-AC71-492D-903D-D36C86DD98F3Q34418763-7F0CCF7A-8E4D-4543-9F8D-186E589877ACQ34449998-823B1BB5-D14E-4650-8836-635A781E837AQ34456981-7AD363AA-B3DB-4D93-9C03-3EBD363372B0Q34531037-951C4482-816E-41E8-AE48-70FB3C227CB0Q34551743-099D15BD-9CCD-4010-BF87-5BA7EA109FCEQ34688370-4F2AE4A5-2A16-49A5-AB2D-97CF6EFB9DFEQ35035498-4278B5B6-7C53-42CE-849C-C5149CB124D8Q35850595-796773B1-577A-45D5-8699-2A61CA9EEB1DQ36031750-D35DE9F6-4DAB-4C93-8741-CA929658A5B3Q36082943-A26725EF-D3DD-4B67-89FD-3F43221A2B27Q36682631-C50FB2BA-6DD8-40AD-9DBF-E3F6AD533692Q36841550-2C728323-7B09-479A-9774-CD85F7500472Q36853232-8394B502-E263-4A3A-8791-8D8C08217A1DQ36902585-E65C9C76-2766-469F-BF40-FAA5BCCAA125Q36986547-57BAFB1F-F74A-45F2-833C-DB00761E1098Q37085440-AA07793B-23B6-4749-B600-162519A816B7Q37141931-7A9FE29B-0EAF-4431-B20F-83BCDADAC8BFQ37186757-4B93E981-D12C-4785-9943-6BB061E4BEDCQ37196862-6D3E9999-CE50-4DB5-868A-B26500741CCDQ37351184-964ECD0F-3D74-43C6-8CF5-F2CB91189273Q37404953-4196376E-1BDF-4E09-BE0F-0279AF3C1DADQ37593401-EB4242C5-F2E6-4CC9-89F3-4C2A26054FFFQ38146934-E3896579-40DC-448A-A024-4D0CAA4BB8B7Q38693282-F43F5A0D-4BD9-469B-BFCA-E3C5419AA33AQ39100540-4217AD1A-1BB7-4969-9792-5408BE1BB2D9Q39404701-45B92422-C639-4020-A0DD-B634064E92ADQ41643573-354FD70C-A47E-4FBE-B4C6-88B1D600F587Q41838379-568E5EBA-676F-4A30-BD8C-0DBDCAF4CAD6Q43195598-BC9E53D0-9BED-4C15-AF8E-FDCE94FAC79CQ43198522-76FD9437-4006-4D1E-B4B5-C0E260E3D366
P2860
Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Collateral damage: cardiovascu ...... c activation with human aging.
@ast
Collateral damage: cardiovascu ...... c activation with human aging.
@en
type
label
Collateral damage: cardiovascu ...... c activation with human aging.
@ast
Collateral damage: cardiovascu ...... c activation with human aging.
@en
prefLabel
Collateral damage: cardiovascu ...... c activation with human aging.
@ast
Collateral damage: cardiovascu ...... c activation with human aging.
@en
P2860
P1476
Collateral damage: cardiovascu ...... c activation with human aging.
@en
P2093
Douglas R Seals
Frank A Dinenno
P2860
P304
P356
10.1152/AJPHEART.00486.2004
P577
2004-11-01T00:00:00Z